TN HB0665 | 2023-2024 | 113th General Assembly
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 26 2023 - 25% progression
Action: 2023-02-01 - Assigned to s/c Health Subcommittee
Text: Latest bill text (Draft #2) [PDF]
Status: Introduced on January 26 2023 - 25% progression
Action: 2023-02-01 - Assigned to s/c Health Subcommittee
Text: Latest bill text (Draft #2) [PDF]
Summary
As introduced, prohibits a healthcare provider from prescribing a buprenorphine product unless the patient has first signed a copy of an informational document on the risks of buprenorphine use to pregnant women, unborn children, and infants; requires the department of health to make available on its public website the informational document within 90 days of the effective date of the act. - Amends TCA Title 53 and Title 63.
Title
AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to buprenorphine.
Sponsors
| Rep. Tim Hicks [R] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-02-01 | House | Assigned to s/c Health Subcommittee |
| 2023-02-01 | House | P2C, ref. to Health Committee |
| 2023-01-30 | House | Intro., P1C. |
| 2023-01-26 | House | Filed for introduction |
Same As/Similar To
SB0733 (Crossfiled) 2023-03-15 - Action deferred in Senate Health and Welfare Committee to 1/24/2024
